Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Axoneural Therapeutics Inc
Profile last edited on: 10/1/22      CAGE: 8MHM4      UEI: MBSCSV9D5SB5

Business Identifier: Nanoparticle-delivered drugs for treatment of traumatic spinal cord injury
Year Founded
2020
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

10000 Cedar Avenue
Cleveland, OH 44106
   (216) 548-6968
   N/A
   N/A
Location: Single
Congr. District: 11
County: 

Public Profile

Originally founded in collaboration with Cleveland Clinic’s Lerner Research Institute with founding research and innovation from Cleveland Clinic, AxoNeural Therapeutics is described as structured around developing nanoparticle-delivered drugs for the treatment of traumatic spinal cord injury

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$399,987
Phase II Dollars
$0
Total Awarded
$399,987

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NIH $399,987
Project Title: Neupron™: a Neuroprotective Agent for Treating Acute Spinal Cord Injury

Key People / Management

  Vinod D Labhasetwar

  Satish Medicetty

  Akhil Saklecha -- Managing Director, Cleveland Clinic Ventures

Company News

There are no news available.